Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol

被引：0
|
作者：
Jennifer E. Lambert
Jill A. Parnell
Bertus Eksteen
Maitreyi Raman
Marc R. Bomhof
Kevin P. Rioux
Karen L. Madsen
Raylene A. Reimer
机构：
[1] University of Calgary,Faculty of Kinesiology
[2] Mount Royal University,Health and Physical Education
[3] University of Calgary,Snyder Institute for Chronic Diseases, Health Research and Innovation Center
[4] University of Calgary,Division of Gastroenterology and Hepatology, Department of Medicine
[5] University of Calgary,Department of Microbiology and Infectious Diseases
[6] University of Alberta,Division of Gastroenterology, Centre of Excellence for Gastrointestinal Inflammation and Immunity Research, 7–142 Katz Group–Rexall Centre
[7] Department of Biochemistry & Molecular Biology,undefined
[8] Cumming School of Medicine,undefined
来源：
BMC Gastroenterology | / 15卷
关键词：
Prebiotic fiber; Gut microbiota; Fatty liver; Weight loss; Fibrosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial
    Saeede Saadati
    Amir Sadeghi
    Asieh Mansour
    Zahra Yari
    Hossein Poustchi
    Mehdi Hedayati
    Behzad Hatami
    Azita Hekmatdoost
    BMC Gastroenterology, 19
  • [42] Gut Dysfunction and Non-alcoholic Fatty Liver Disease
    Grabherr, Felix
    Grander, Christoph
    Effenberger, Maria
    Adolph, Timon Erik
    Tilg, Herbert
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [43] Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex Interplay
    Abenavoli, Ludovico
    Giubilei, Lidia
    Procopio, Anna Caterina
    Spagnuolo, Rocco
    Luzza, Francesco
    Boccuto, Luigi
    Scarpellini, Emidio
    NUTRIENTS, 2022, 14 (24)
  • [44] The effects of supplementation of probiotics, prebiotics, or synbiotics on patients with non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trials
    Xing, Wenmin
    Gao, Wenyan
    Lv, Xiaoling
    Zhao, Zhenlei
    Mao, Genxiang
    Dong, Xiaoyan
    Zhang, Zuyong
    FRONTIERS IN NUTRITION, 2022, 9
  • [45] Role of Nutrition, Gene Polymorphism, and Gut Microbiota in Non-alcoholic Fatty Liver Disease
    Kong, Lingbo
    Lu, Yu
    Zhang, Siyu
    Nan, Yuemin
    Qiao, Liang
    DISCOVERY MEDICINE, 2017, 24 (131) : 95 - 106
  • [46] Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota
    Han, Ruiting
    Ma, Junli
    Li, Houkai
    FRONTIERS OF MEDICINE, 2018, 12 (06) : 645 - 657
  • [47] Modulation of the gut microbiota represents a new management for non-alcoholic fatty liver disease
    Bakhshimoghaddam, Farnush
    Alizadeh, Mohammad
    HEPATOBILIARY SURGERY AND NUTRITION, 2020, 9 (02) : 223 - 226
  • [48] Gut microbiota induced epigenetic modifications in the non-alcoholic fatty liver disease pathogenesis
    Tang, Ruiqi
    Liu, Rongrong
    Zha, Hua
    Cheng, Yiwen
    Ling, Zongxin
    Li, Lanjuan
    ENGINEERING IN LIFE SCIENCES, 2024, 24 (05):
  • [49] Phenotyping non-alcoholic fatty liver disease by the gut microbiota: Ready for prime time?
    Demir, Muenevver
    Lang, Sonja
    Martin, Anna
    Farowski, Fedja
    Wisplinghoff, Hilmar
    Vehreschild, Maria J. G. T.
    Krawczyk, Marcin
    Nowag, Angela
    Scholz, Claus Jurgen
    Kretzschmar, Anne
    Roderburg, Christoph
    Lammert, Frank
    Goeser, Tobias
    Kasper, Philipp
    Steffen, Hans-Michael
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (11) : 1969 - 1977
  • [50] Role of the Gut Microbiota in Regulating Non-alcoholic Fatty Liver Disease in Children and Adolescents
    Tokuhara, Daisuke
    FRONTIERS IN NUTRITION, 2021, 8
12345